Showing results (421-430 of 495) with videos related to
Sort By:
Pageof 50
Gynecologic Oncology|December 17, 2009
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinomaJohn P Diaz, William P Tew, Oliver Zivanovic, et al.Gynecologic Oncology|September 26, 2006
CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapyMargrit M Juretzka, Richard R Barakat, Dennis S Chi, et al.Gynecologic Oncology|December 23, 2008
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinomaDennis S Chi, Oliver Zivanovic, Meena J Palayekar, et al.Gynecologic Oncology|August 12, 2009
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancerOliver Zivanovic, Camelia S Sima, Alexia Iasonos, et al.Gynecologic Oncology|September 11, 2013
Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidityKara C Long, Edward J Tanner, Melissa Frey, et al.Cancer|March 31, 2006
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinomaDennis S Chi, Kristina McCaughty, John P Diaz, et al.Gynecologic Oncology|October 9, 2013
Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasionChristine H Kim, Fady Khoury-Collado, Emma L Barber, et al.Gynecologic Oncology|December 22, 2009
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentumOliver Zivanovic, Camelia S Sima, Alexia Iasonos, et al.Gynecologic Oncology|February 28, 2012
The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodesJoyce N Barlin, Fady Khoury-Collado, Christine H Kim, et al.International Journal of Cancer|October 2, 2003
MSH6 germline mutations are rare in colorectal cancer familiesPaolo Peterlongo, Khedoudja Nafa, Gabriel S Lerman, et al.Pageof 50